Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Ocul Immunol Inflamm ; 30(6): 1312-1314, 2022 Aug.
Article in English | MEDLINE | ID: covidwho-2151400

ABSTRACT

AIM: We report a new ocular finding of episcleritis (OD) and peripheral ulcerative keratitis (OS) in a 40-year-old lady with a 13-year history of systemic lupus erythematosus (SLE), 3 weeks post-rituximab infusion. MATERIALS & METHODS: Retrospective case report. RESULTS: A 40-year-old lady with a history of SLE and 3 weeks post rituximab infusion developed a new onset episcleritis (OD) and peripheral ulcerative keratitis (OS). As the PUK continued to advance with a leading edge, intravenous methyl prednisolone 1 gm/day was given for 3 days followed by a slow tapering course of oral prednisolone 50 mg/day. Though her ocular inflammation resolved, she developed pneumonia 6 weeks later. At 10 months follow-up, there were no ocular recurrences. She is currently on mycophenolate mofetil 2 gm/day along with oral prednisolone of 10 mg/day. CONCLUSION: This case highlights the new occurrence of episcleritis and PUK in SLE post-rituximab infusion.


Subject(s)
Corneal Ulcer , Lupus Erythematosus, Systemic , Scleritis , Humans , Female , Adult , Rituximab/adverse effects , Corneal Ulcer/chemically induced , Corneal Ulcer/diagnosis , Corneal Ulcer/drug therapy , Scleritis/diagnosis , Scleritis/drug therapy , Scleritis/etiology , Retrospective Studies , Lupus Erythematosus, Systemic/diagnosis , Lupus Erythematosus, Systemic/drug therapy , Methylprednisolone
SELECTION OF CITATIONS
SEARCH DETAIL